Trial Profile
TK-FT Pharmacokinetic Study (Patients)
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Teikoku Seiyaku
- 31 May 2016 New trial record